Oaktree Insurance Dedicated Fund Series has sold $110,609,023 through an indefinite exempt securities offering. The amount identifies Capital already raised by the fund, while the structure places SALI Fund Partners, LLC as general partner and Cameron Vail as its managing director.
Key Highlights
- The offering notice is dated 10 September 2026 and identifies the fund as a Delaware limited partnership.
- SALI Fund Partners, LLC serves as general partner, with Cameron Vail named managing director.
- The offering cites exemptions under 06b, 3C and 3C.7.
Oaktree Insurance Dedicated Fund Series of the SALI Multi-Series Fund, L.P. has sold $110,609,023 through an indefinite exempt securities offering. The offering notice carries the date 10 September 2026 and identifies the fund’s Austin, Texas address as 6850 Austin Center Boulevard, Suite 300. The fund is associated with SALI Fund Partners, LLC, which is named as the general partner. Cameron Vail is identified as managing director of the general partner. The notice lists exemptions under 06b, 3C and 3C.7.
Fund Structure and Offering Classification
The notice identifies all states as the offering’s jurisdictional scope. The fund’s offering information also identifies 7 January 2025 in connection with the reported offering data.
FAQs
Q: How much has Oaktree Insurance Dedicated Fund Series sold?
A: Oaktree Insurance Dedicated Fund Series has sold $110,609,023 through an indefinite exempt securities offering. The offering is associated with the SALI Multi-Series Fund.
Q: What is the investment fund’s legal structure?
A: Oaktree Insurance Dedicated Fund Series is a Delaware limited partnership classified as an other investment fund. Its listed jurisdictional scope covers all states.
Q: Who manages Oaktree Insurance Dedicated Fund Series?
A: SALI Fund Partners, LLC is identified as the general partner. Cameron Vail is named managing director of the general partner and signed for the fund.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.